翻訳と辞書
Words near each other
・ Medicare and Medicaid Extenders Act of 2010
・ Medicare Australia
・ Medicare card
・ Medicare cost report
・ Medicare dual eligible
・ Medicare fraud
・ Medicare Fraud Strike Force
・ Medicare Improvements for Patients and Providers Act of 2008
・ Medicare Part D
・ Medicare Part D coverage gap
・ Medicare Payment Advisory Commission
・ Medicare Physician Group Practice (PGP) Demonstration
・ Medicare Prescription Drug Price Negotiation Act of 2007
・ Medicare Prescription Drug, Improvement, and Modernization Act
・ Medicare Prompt Pay Correction Act
Medicare Quality Cancer Care Demonstration Act
・ Medicare Resources
・ Medicare Rights Center
・ Medicare Sustainable Growth Rate
・ Medicare, Medicaid, and SCHIP Balanced Budget Refinement Act of 1999
・ Medicarpin
・ Medicate
・ Medication (band)
・ Medication (disambiguation)
・ Medication Administration Record
・ Medication overuse headache
・ Medication phobia
・ Medication therapy management
・ Medication-induced hyperlipoproteinemia
・ Medications used in dentistry and periodontics


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Medicare Quality Cancer Care Demonstration Act : ウィキペディア英語版
Medicare Quality Cancer Care Demonstration Act

The United States Medicare Quality Cancer Care Demonstration Act of 2009 () is a landmark, national initiative intended to enhance the quality of cancer care, focused on seniors covered by Medicare (approximately 45% of cancer patients are Medicare beneficiaries), while also controlling costs. House bill H.R. 2872 was introduced by Congressman Artur Davis (D-AL) and cosponsored by Representatives Steve Israel (D-NY) and Mary Jo Kilroy (D-OH).
The Quality Cancer Care Demonstration (QCCD) project was developed by community oncologists, with input from policy experts, to be a national Medicare demonstration project focused on two key aspects of cancer care: treatment planning and end-of-life care. Treatment planning involves all of the essential components of establishing the cancer care plan and monitoring its effectiveness. End-of-life care involves all of the essential components of patient-centric cancer care relating to individuals facing end-of-life planning and decisions.
H.R. 2872 calls for national reporting, via the Medicare payment system, of key metrics of evidence based care, refinement of those metrics, and development of a new Medicare performance-based reimbursement system that is patient-centric and quality driven, while aligning better with parameters of cost control.
The bill includes the following elements:
*Establishes a national Medicare demonstration project to be implemented by the Centers for Medicare & Medicaid Services (CMS) open to all oncology practices.
*Designed to address current shortcomings in quality metrics and aligned incentives in the areas of treatment planning and end-of-life care.
*Involves the reporting by oncologists, via the Medicare reimbursement system, of performance quality measures relating to treatment planning and end-of-life care and the refinement of those measures.
*Allocates $300 million per year in Medicare funding to produce a revised payment system based on quality and cost-efficiency in a true pay-for-performance model.
*Incorporates the key elements under discussion in the healthcare reform debate — quality care delivery, evidence-based medicine, care coordination, patient-centric, cost control, health information technology, and pay-for-performance — in producing an evolved payment system.
*Action-oriented and not another concept — substantive, developed project that can be implemented within 6 months by CMS open to all oncology practices nationwide.
*Can serve as a model for other areas of medical care.



抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Medicare Quality Cancer Care Demonstration Act」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.